SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Nicholas V. DiPatrizio, Is fat taste ready for primetime?, Physiology & Behavior, 2014, 136, 145

    CrossRef

  2. 2
    Seiya Miyamoto, Lars F. Jarskog, W. Wolfgang Fleischhacker, Alternative pharmacologic targets for the treatment of schizophrenia, Current Opinion in Psychiatry, 2013, 26, 2, 158

    CrossRef

  3. 3
    K. M. Habegger, H. Kirchner, C.-X. Yi, K. M. Heppner, D. Sweeney, N. Ottaway, J. Holland, S. Amburgy, C. Raver, R. Krishna, T. D. Muller, D. Perez-Tilve, P. T. Pfluger, S. Obici, R. D. DiMarchi, D. A. D'Alessio, R. J. Seeley, M. H. Tschop, GLP-1R Agonism Enhances Adjustable Gastric Banding in Diet-Induced Obese Rats, Diabetes, 2013, 62, 9, 3261

    CrossRef

  4. 4
    Ikram Merroun, Cristina Sánchez-González, Rosario Martínez, Carlos López-Chaves, Jesús M. Porres, Pilar Aranda, Juan Llopis, Milagros Galisteo, Antonio Zarzuelo, Mohammed Errami, María López-Jurado, Novel effects of the cannabinoid inverse agonist AM 251 on parameters related to metabolic syndrome in obese Zucker rats, Metabolism, 2013, 62, 11, 1641

    CrossRef

  5. 5
    E T Wargent, M S Zaibi, C Silvestri, D C Hislop, C J Stocker, C G Stott, G W Guy, M Duncan, V Di Marzo, M A Cawthorne, The cannabinoid Δ9-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity, Nutrition & Diabetes, 2013, 3, 5, e68

    CrossRef

  6. 6
    Nina L. Cluny, Raylene A. Reimer, Keith A. Sharkey, Cannabinoid signalling regulates inflammation and energy balance: The importance of the brain–gut axis, Brain, Behavior, and Immunity, 2012, 26, 5, 691

    CrossRef

  7. 7
    Li-Na Zhang, Yuko Gamo, Rachel Sinclair, Sharon E. Mitchell, David G. Morgan, John C. Clapham, John R. Speakman, Effects of Chronic Oral Rimonabant Administration on Energy Budgets of Diet-Induced Obese C57BL/6 Mice, Obesity, 2012, 20, 5
  8. 8
    Heather L. Hutchins-Wiese, Yong Li, Kevin Hannon, Bruce A. Watkins, Hind limb suspension and long-chain omega-3 PUFA increase mRNA endocannabinoid system levels in skeletal muscle, The Journal of Nutritional Biochemistry, 2012, 23, 8, 986

    CrossRef

  9. 9
    K. Rohrbach, M. A. Thomas, S. Glick, E. N. Fung, V. Wang, L. Watson, P. Gregory, J. Antel, M. A. Pelleymounter, Ibipinabant attenuates β-cell loss in male Zucker diabetic fatty rats independently of its effects on body weight, Diabetes, Obesity and Metabolism, 2012, 14, 6
  10. 10
    Andrea Mastinu, Marilena Pira, Luca Pani, Gérard Aimè Pinna, Paolo Lazzari, NESS038C6, a novel selective CB1 antagonist agent with anti-obesity activity and improved molecular profile, Behavioural Brain Research, 2012, 234, 2, 192

    CrossRef

  11. 11
    S Miyamoto, N Miyake, L F Jarskog, W W Fleischhacker, J A Lieberman, Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents, Molecular Psychiatry, 2012, 17, 12, 1206

    CrossRef

  12. 12
    A. Díaz-Arteaga, M. J. Vázquez, R. Vazquez-Martínez, M. R. Pulido, J. Suarez, D. A. Velásquez, M. López, R. A. Ross, F. Rodriguez de Fonseca, F. J. Bermudez-Silva, M. M. Malagón, C. Diéguez, R. Nogueiras, The atypical cannabinoid O-1602 stimulates food intake and adiposity in rats, Diabetes, Obesity and Metabolism, 2012, 14, 3
  13. 13
    Nicholas V. DiPatrizio, Daniele Piomelli, The thrifty lipids: endocannabinoids and the neural control of energy conservation, Trends in Neurosciences, 2012, 35, 7, 403

    CrossRef

  14. 14
    Janice D. Wagner, Jennifer A. Cann, Li Zhang, H. James Harwood, Nonhuman Primates in Biomedical Research, 2012,

    CrossRef

  15. 15
    D. Song, R. H. J. Bandsma, C. Xiao, L. Xi, W. Shao, T. Jin, G. F. Lewis, Acute cannabinoid receptor type 1 (CB1R) modulation influences insulin sensitivity by an effect outside the central nervous system in mice, Diabetologia, 2011, 54, 5, 1181

    CrossRef

  16. 16
    David R Janero, Loren Lindsley, Venkata Kiran Vemuri, Alexandros Makriyannis, Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk, Expert Opinion on Drug Discovery, 2011, 6, 10, 995

    CrossRef

  17. 17
    M. Bajzer, M. Olivieri, M. K. Haas, P. T. Pfluger, I. J. Magrisso, M. T. Foster, M. H. Tschöp, K. A. Krawczewski-Carhuatanta, D. Cota, S. Obici, Cannabinoid receptor 1 (CB1) antagonism enhances glucose utilisation and activates brown adipose tissue in diet-induced obese mice, Diabetologia, 2011, 54, 12, 3121

    CrossRef

  18. 18
    J. D. O'Hare, E. Zielinski, B. Cheng, T. Scherer, C. Buettner, Central Endocannabinoid Signaling Regulates Hepatic Glucose Production and Systemic Lipolysis, Diabetes, 2011, 60, 4, 1055

    CrossRef

  19. 19
    K S Bell-Anderson, L Aouad, H Williams, F R Sanz, J Phuyal, C Z Larter, G C Farrell, I D Caterson, Coordinated improvement in glucose tolerance, liver steatosis and obesity-associated inflammation by cannabinoid 1 receptor antagonism in fat Aussie mice, International Journal of Obesity, 2011, 35, 12, 1539

    CrossRef

  20. 20
    Qun Wang, Xiaoyuan D. Perrard, Jerry L. Perrard, Amir Mansoori, C. Wayne Smith, Christie M. Ballantyne, Huaizhu Wu, Effect of the Cannabinoid Receptor-1 Antagonist Rimonabant on Inflammation in Mice With Diet-Induced Obesity, Obesity, 2011, 19, 3
  21. 21
    Deanna L. Kelly, David A. Gorelick, Robert R. Conley, Douglas L. Boggs, Jared Linthicum, Fang Liu, Stephanie Feldman, M. Patricia Ball, Heidi J. Wehring, Robert P. McMahon, Marilyn A. Huestis, Stephen J. Heishman, Kimberly R. Warren, Robert W. Buchanan, Effects of the Cannabinoid-1 Receptor Antagonist Rimonabant on Psychiatric Symptoms in Overweight People With Schizophrenia, Journal of Clinical Psychopharmacology, 2011, 31, 1, 86

    CrossRef

  22. 22
    Carmelo Quarta, Roberta Mazza, Silvana Obici, Renato Pasquali, Uberto Pagotto, Energy balance regulation by endocannabinoids at central and peripheral levels, Trends in Molecular Medicine, 2011, 17, 9, 518

    CrossRef

  23. 23
    Patricia Rivera, Yanina Romero-Zerbo, Francisco J. Pavón, Antonia Serrano, María-Dolores López-Ávalos, Manuel Cifuentes, Jesús-Mateos Grondona, Francisco-Javier Bermúdez-Silva, Pedro Fernández-Llebrez, Fernando R. de Fonseca, Juan Suárez, Margarita Pérez-Martín, Obesity-dependent cannabinoid modulation of proliferation in adult neurogenic regions, European Journal of Neuroscience, 2011, 33, 9
  24. 24
    Nina L. Cluny, Adam P. Chambers, V. Kiran Vemuri, JodiAnne T. Wood, Lindsay K. Eller, Carmelina Freni, Raylene A. Reimer, Alexandros Makriyannis, Keith A. Sharkey, The neutral cannabinoid CB1 receptor antagonist AM4113 regulates body weight through changes in energy intake in the rat, Pharmacology Biochemistry and Behavior, 2011, 97, 3, 537

    CrossRef

  25. 25
    Jose M. Miguel-Yanes, Alisa K. Manning, Peter Shrader, Jarred B. McAteer, Anuj Goel, Anders Hamsten, Caroline S. Fox, Jose C. Florez, Josée Dupuis, James B. Meigs, Variants at the Endocannabinoid Receptor CB1 Gene (CNR1) and Insulin Sensitivity, Type 2 Diabetes, and Coronary Heart Disease, Obesity, 2011, 19, 10
  26. 26
    Paolo Lazzari, Angela Sanna, Andrea Mastinu, Simona Cabasino, Ilaria Manca, Luca Pani, Weight loss induced by rimonabant is associated with an altered leptin expression and hypothalamic leptin signaling in diet-induced obese mice, Behavioural Brain Research, 2011, 217, 2, 432

    CrossRef

  27. 27
    Mohammad R. Hayatbakhsh, Michael J. O'Callaghan, Abdullah A. Mamun, Gail M. Williams, Alexandra Clavarino, Jake M. Najman, Cannabis Use and Obesity and Young Adults, The American Journal of Drug and Alcohol Abuse, 2010, 36, 6, 350

    CrossRef

  28. 28
    Carmelo Quarta, Luigi Bellocchio, Giacomo Mancini, Roberta Mazza, Cristina Cervino, Luzie J. Braulke, Csaba Fekete, Rocco Latorre, Cristina Nanni, Marco Bucci, Laura E. Clemens, Gerhard Heldmaier, Masahiko Watanabe, Thierry Leste-Lassere, Marlène Maitre, Laura Tedesco, Flaminia Fanelli, Stefan Reuss, Susanne Klaus, Raj Kamal Srivastava, Krisztina Monory, Alessandra Valerio, Annamaria Grandis, Roberto De Giorgio, Renato Pasquali, Enzo Nisoli, Daniela Cota, Beat Lutz, Giovanni Marsicano, Uberto Pagotto, CB1 Signaling in Forebrain and Sympathetic Neurons Is a Key Determinant of Endocannabinoid Actions on Energy Balance, Cell Metabolism, 2010, 11, 4, 273

    CrossRef

  29. 29
    G.A. Kennett, P.G. Clifton, New approaches to the pharmacological treatment of obesity: Can they break through the efficacy barrier?, Pharmacology Biochemistry and Behavior, 2010, 97, 1, 63

    CrossRef

  30. 30
    C. Lipina, C. Stretton, S. Hastings, J. S. Hundal, K. Mackie, A. J. Irving, H. S. Hundal, Regulation of MAP Kinase-Directed Mitogenic and Protein Kinase B-Mediated Signaling by Cannabinoid Receptor Type 1 in Skeletal Muscle Cells, Diabetes, 2010, 59, 2, 375

    CrossRef

  31. 31
    Akhlaq A. Farooqui, Tahira Farooqui, Contribution of Phospholipid, Sphingolipids, and Cholesterol-Derived Lipid Mediators in the Pathogenesis of Metabolic Syndrome and Neurological Disorders,